Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3
Portfolio Pulse from Avi Kapoor
Insiders at Iterum Therapeutics, Retractable Technologies, Collective Audience, and NetSol Technologies have recently made notable purchases of their companies' stocks, all priced under $3. These transactions may signal insider confidence in the companies' prospects. Iterum Therapeutics regained Nasdaq compliance, Retractable Technologies reported an operational loss, Collective Audience appointed a new CEO, and NetSol Technologies saw an increase in quarterly sales.
December 28, 2023 | 2:18 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Collective Audience Director Denis Duncan bought 20,000 shares at $1.24 each, following the appointment of a new CEO, Peter Bordes.
The director's purchase combined with new leadership could suggest a positive outlook, potentially leading to a short-term uptick in the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
POSITIVE IMPACT
Iterum Therapeutics Director Michael W Dunne bought 25,000 shares at $1.40 each, signaling confidence as the company regains Nasdaq compliance.
Insider purchases often indicate bullish sentiment from company leadership, especially following positive compliance news with Nasdaq, which could lead to short-term positive impact on the stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
NetSol Technologies President Naeem Ghauri bought 6,172 shares at $2.08 each, aligning with the company's reported increase in quarterly sales.
The president's investment in the company's stock, especially after reporting increased sales, is likely to be viewed positively by investors, suggesting a potential short-term positive impact on the stock price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Retractable Technologies' President and CEO Thomas J Shaw bought 7,706 shares at $1.10 each despite the company reporting an operational loss for the first nine months of 2023.
The CEO's purchase could be seen as a positive sign, but the recent operational loss may temper investor enthusiasm, leading to a neutral short-term impact.
CONFIDENCE 65
IMPORTANCE 60
RELEVANCE 70